SCHEMBL6318130

SCHEMBL6318130

O=C(O)C(=O)Nc1ccc2cc[nH]c2c1C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 8/20 1.00
PTPN2 P17706 5/20 1.00
PTPRC P08575 4/20 1.00
PTPRB P23467 4/20 1.00
PTPRE P23469 4/20 1.00
PTPN6 P29350 4/20 1.00
KEAP1 Q14145 1/20 0.42
PTPRA P18433 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
ENPP2 Q13822 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GPR35 Q9HC97 3/20 0.38
BCHE P06276 2/20 0.36
PDPK1 O15530 1/20 0.35
PTPRF P10586 2/20 0.35
BACE1 P56817 1/20 0.34
PTPN11 Q06124 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601830 0.76 PTPRC (0.61) PTPN1PTPN2PTPRCPTPRBPTPRE
SCHEMBL31438296 0.74 PTPRC (0.58) PTPN1PTPN2PTPRCPTPRBPTPRE
SCHEMBL3982699 0.73 METAP2 (0.63) PTPN1PTPN2PTPRCPTPRBPTPRE
SCHEMBL4084024 0.71 PTPRC (0.55) PTPN1PTPN2PTPRCPTPRBPTPRE
SCHEMBL5188581 0.71 PTPRC (0.55) PTPN1PTPN2PTPRCPTPRBPTPRE
SCHEMBL16461458 0.70 CFTR (0.60) PTPN1PTPN2PTPRCPTPRBPTPRE
SCHEMBL11835239 0.70 GPR35 (0.64) PTPN1PTPN2PTPRCPTPRBPTPRE
SCHEMBL3982706 0.70 PTPRC (0.53) PTPN1PTPN2PTPRCPTPRBPTPRE
SCHEMBL3988437 0.70 METAP2 (0.62) PTPN1PTPN2PTPRCPTPRBPTPRE
SCHEMBL6321219 0.70 PTPRC (0.53) PTPN1PTPN2PTPRCPTPRBPTPRE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030069267-A1 Modulators of protein tyrosine phosphatases (PTPases) MOLLER NIELS PETER HUNDAHL (DK) 2003-04-10 US claimed
CN-1300291-A Modulators of protein tyrosine phosphatases (PTP enzymes) NOVO NORDISK AS (DK) 2001-06-20 CN claimed
EP-1080095-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2001-03-07 EP claimed
WO-1999046267-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 1999-09-16 WO claimed
US-6951878-B2 Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases) NOVO NORDISK A/S (DK) 2005-10-04 US disclosed
US-20030069267-A1 Modulators of protein tyrosine phosphatases (PTPases) MOLLER NIELS PETER HUNDAHL (DK) 2003-04-10 US disclosed
US-6410586-B1 ANTICOAGULANTS; INSULIN RESISTANCE; ANTIALLERGENS NOVO NORDISK A/S (DK) 2002-06-25 US disclosed
US-6262044-B1 CONTAINING AN AMIDE-SUBSTITUTED TETRAHYDROTHIENOPYRIDINE RING NOVO NORDISK A/S (DK) 2001-07-17 US disclosed
CN-1300291-A Modulators of protein tyrosine phosphatases (PTP enzymes) NOVO NORDISK AS (DK) 2001-06-20 CN disclosed
EP-1080095-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2001-03-07 EP disclosed
EP-1080068-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES Novo Nordisk A/S (DK) 2001-03-07 EP disclosed
WO-1999046267-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 1999-09-16 WO disclosed
WO-1999046237-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES NOVO NORDISK A/S (DK) 1999-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069267-A1 Modulators of protein tyrosine phosphatases (PTPases) PTPRCAP, PTPRS, PTPRA PTPN1 7/4885PTPN2 9/4885PTPRC 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.